Pattern of second primary neoplasms following breast cancer
โ Scribed by Parikh, Bhavna; Advani, Suresh
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 285 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
โฆ Synopsis
Background: Second primary neoplasms (SPN) have been seen with diseases such as breast cancer and Hodgkin's disease. Therapeutic agents used for their treatment have been found responsible for the development of SPN in some cases. In addition, genetic factors are known to contribute to their development.
Methods:
A retrospective study of 15 patients who had primary breast cancer and developed SPN concurrently or sequentially was conducted. Results: Of 15 patients analysed in this study, five had haematological SPN, four had ovarian cancer, and six had different types of non-haematological SPN. Familial clustering was found in two patients. A peculiar abnormality of chromosome 5 and 7 was detected in one patient with haematological SPN, suggesting therapy-related leukeamia. Conclusions: It is postulated that alkylating agents with or without pS3 gene inactivation may predispose to leukaemia, whereas ovarian tumours following breast cancer could be related to BRCA 1 gene inactivation.
๐ SIMILAR VOLUMES
Carcinoma in situ (CIS) of the breast has increased manyfold in incidence rates and as a proportion of new breast cancers following the introduction of mammographic breast screening. To provide population-based estimates of invasive breast cancer risk following CIS, we linked data on 249 incident pr
Of 984 patients with corpus cancer treated at Roswell Park Memorial Institute (between 1940 and 1960), 116 (11.8%) were found to have second primaries; of these, 47 had breast cancer, 15 skin cancer, 27 other pelvic cancers, 15 abdominal cancer, 3 head and neck cancer, and 3 lymphoma or leukemia. T
Comparative genomic hybridization (CGH) reveals DNA sequence copy number changes that are shared among the different cell subpopulations present in a tumor and may help to delineate the average progression pathways of breast cancer. Previous CGH studies of breast cancer have concentrated on selected